Organic phosphonic acids and derivatives
Accela Chembio Inc MF: C10H21O5P | MW: 252.24 | >97% | BP: 152¿C/12mmHg | Density: 1.0700.
MF: C10H21O5P | MW: 252.24 | >97% | BP: 152¿C/12mmHg | Density: 1.0700.
eMolecules 38011-77-7 | 1-(3-BROMOPROPYL)-2-METHOXYBENZENE | AstaTech | MFCD00017896 | 229.117 | C10H13BrO | 97.000 | COc1ccccc1CCCBr | 0.25g | 448274305
1-(3-BROMOPROPYL)-2-METHOXYBENZENE | AstaTech | 38011-77-7 | MFCD00017896 | 229.117 | C10H13BrO | 97.000 | COc1ccccc1CCCBr | 0.25g | 448274305
eMolecules 171856-09-0 | Fmoc-N-(4-Boc-aminobutyl)-Gly-OH | Ambeed | MFCD04112689 | 468.550 | C26H32N2O6 | 98.000 | CC(C)(C)OC(=O)NCCCCN(CC(O)=O)C(=O)OCC1c2ccccc2-c2ccccc12 | 1g | 572980078
Fmoc-N-(4-Boc-aminobutyl)-Gly-OH | Ambeed | 171856-09-0 | MFCD04112689 | 468.550 | C26H32N2O6 | 98.000 | CC(C)(C)OC(=O)NCCCCN(CC(O)=O)C(=O)OCC1c2ccccc2-c2ccccc12 | 1g | 572980078
Enzo Life Sciences Methyl Arachidonyl Fluorophosphonate (25 mg). CAS: 188404-10-6
Selective, active-site directed, irreversible inhibitor of cPLA2 (IC50=5µM) and Ca2+-independent iPLA2 (IC50=0.5µM). Potent, irreversible inhibitor of fatty acid amide hydrolase (FAAH) (IC50=2.5nM), 800 -fold more potent than AACOCF3 (BML-ST335)). Irriversible CB1 receptor antagonist in rat brain membrane (IC50=20nM). Alternative name: MAFP, Methylphosphonofluoridic acid 5,8,11,14-eicosatetraenyl ester. Purity: ≥98% (TLC). Solubility: Soluble in 100% ethanol (50mg/ml) or DMSO (50mg/ml). Long Term Storage: -80°C.
eMolecules 54877-27-9 | 1-(3-Bromopropyl)-2-chlorobenzene | Combi-Blocks | MFCD09744362 | 233.530 | C9H10BrCl | 98.000 | Clc1ccccc1CCCBr | 1g | 117543877
1-(3-Bromopropyl)-2-chlorobenzene | Combi-Blocks | 54877-27-9 | MFCD09744362 | 233.530 | C9H10BrCl | 98.000 | Clc1ccccc1CCCBr | 1g | 117543877
eMolecules 57293-19-3 | Ambeed | 1-(3-Bromopropyl)-4-methoxybenzene | 250mg | 531649104 | A822151 | MFCD00155066 | 229.117 | C10H13BrO
Ambeed | 1-(3-Bromopropyl)-4-methoxybenzene | 250mg | 531649104 | A822151 | 57293-19-3 | MFCD00155066 | 229.117 | C10H13BrO
eMolecules 4721-24-8 | n-Hexylphosphonic acid, min. 97% HPA | Strem Chemicals | MFCD00013961 | 166.157 | C6H15O3P | 97.000 | CCCCCCP(O)(O)=O | 1g | 321336444
n-Hexylphosphonic acid, min. 97% HPA | Strem Chemicals | 4721-24-8 | MFCD00013961 | 166.157 | C6H15O3P | 97.000 | CCCCCCP(O)(O)=O | 1g | 321336444
![eMolecules 171856-09-0 | N-[4-(Boc-amino)butyl]-N-Fmoc-glycine | Acrotein ChemBio Inc. | MFCD04112689 | 468.550 | C26H32N2O6 | 97.000 | CC(C)(C)OC(=O)NCCCCN(CC(O)=O)C(=O)OCC1c2ccccc2-c2ccccc12 | 1g | 518515086](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000165290.jpg-250.jpg)
eMolecules 171856-09-0 | N-[4-(Boc-amino)butyl]-N-Fmoc-glycine | Acrotein ChemBio Inc. | MFCD04112689 | 468.550 | C26H32N2O6 | 97.000 | CC(C)(C)OC(=O)NCCCCN(CC(O)=O)C(=O)OCC1c2ccccc2-c2ccccc12 | 1g | 518515086
N-[4-(Boc-amino)butyl]-N-Fmoc-glycine | Acrotein ChemBio Inc. | 171856-09-0 | MFCD04112689 | 468.550 | C26H32N2O6 | 97.000 | CC(C)(C)OC(=O)NCCCCN(CC(O)=O)C(=O)OCC1c2ccccc2-c2ccccc12 | 1g | 518515086
Cambridge Isotope Laboratories Ethyl hydrogen methylphosphonate (ethyl-D5 98%) 100 ug/mL in methanol 1 2 mL
Ethyl hydrogen methylphosphonate (ethyl-D5 98%) 100 ug/mL in methanol 1 2 mL
eMolecules 35622-27-6 | (4-Aminobutyl)phosphonic acid | Combi-Blocks | MFCD00063426 | 153.118 | C4H12NO3P | 98.000 | NCCCCP(O)(O)=O | 1g | 495743365
(4-Aminobutyl)phosphonic acid | Combi-Blocks | 35622-27-6 | MFCD00063426 | 153.118 | C4H12NO3P | 98.000 | NCCCCP(O)(O)=O | 1g | 495743365
eMolecules 36969-89-8 | Dimethyl (2-oxoheptyl)phosphonate | Combi-Blocks | MFCD00009514 | 222.221 | C9H19O4P | 95.000 | CCCCCC(=O)CP(=O)(OC)OC | 25g | 457916969
Dimethyl (2-oxoheptyl)phosphonate | Combi-Blocks | 36969-89-8 | MFCD00009514 | 222.221 | C9H19O4P | 95.000 | CCCCCC(=O)CP(=O)(OC)OC | 25g | 457916969